File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1038/sj.bjp.0706256
- Scopus: eid_2-s2.0-23044461193
- PMID: 15895105
- WOS: WOS:000230588500010
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: Involvement of potassium channel activation and epoxyeicosatrienoic acids
Title | Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: Involvement of potassium channel activation and epoxyeicosatrienoic acids |
---|---|
Authors | |
Keywords | 11,12-EET 14,15-EET 14,15-EEZE 14,15-EEZE-mSI 5,6-EET Bradykinin EDHF Endothelium-dependent hyperpolarization Porcine coronary artery Substance P |
Issue Date | 2005 |
Publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1 |
Citation | British Journal Of Pharmacology, 2005, v. 145 n. 6, p. 775-784 How to Cite? |
Abstract | In coronary arteries, bradykinin opens endothelial intermediate- and small-conductance Ca 2+-sensitive K + channels (IK Ca and SK Ca) and, additionally, releases epoxyeicosatrienoic acids (EETs) from the endothelium. To clarify the involvement of these pathways in endothelium-dependent myocyte hyperpolarization, bradykinin-induced electrical changes in endothelial cells and myocytes of porcine coronary arteries (following nitric oxide (NO) synthase and cyclooxygenase inhibition) were measured using sharp microelectrodes. Hyperpolarization of endothelial cells by bradykinin (27.0±0.9 mV, n = 4) was partially inhibited (74%) by blockade of IK Ca and SK Ca channels using 10 μM TRAM-39 (2-(2-chlorophenyl)-2,2- diphenylacetonitrile) plus 100 nM apamin (leaving an iberiotoxin-sensitive component), whereas the response to substance P was abolished. After gap junction blockade with HEPES, (N-(2-hydroxyethyl)piperazine-N′-(2- ethanesulphonic acid)) hyperpolarization of the endothelium by 100 nM bradykinin was abolished by TRAM-39 plus apamin, whereas myocyte hyperpolarization still occurred (12.9 ± 1.0 mV, n = 4). The residual hyperpolarizations to 100 nM bradykinin were antagonized by the EET antagonist, 14,15-EEZE (14,15-epoxyeicosa-5(Z)-enoic acid) (10 μM), and abolished by iberiotoxin. Bradykinin-induced myocyte hyperpolarizations were also reduced by 14,15-EEZE-mSI (14,15-EEZE-methylsulfonylimide) (5,6- and 14,15-EET antagonist), whereas those to exogenous 11,12-EET were unaffected. These data show that bradykinin-induced hyperpolarization of endothelial cells (due to the opening of IK Ca and SK Ca channels) is electrotonically transferred to the myocytes via gap junctions. Bradykinin (but not substance P) also hyperpolarizes myocytes by a mechanism (independent of endothelial cell hyperpolarization) which involves endothelial cell production of EETs (most likely 14,15- and/or 11,12-EET). These open endothelial IK Ca and SK Ca channels and also activate large-conductance calcium-sensitive K + channels (BK Ca) on the surrounding myocytes. © 2005 Nature Publishing Group. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/171333 |
ISSN | 2023 Impact Factor: 6.8 2023 SCImago Journal Rankings: 2.119 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Weston, AH | en_US |
dc.contributor.author | Félétou, M | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.contributor.author | Falck, JR | en_US |
dc.contributor.author | Campbell, WB | en_US |
dc.contributor.author | Edwards, G | en_US |
dc.date.accessioned | 2012-10-30T06:13:27Z | - |
dc.date.available | 2012-10-30T06:13:27Z | - |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | British Journal Of Pharmacology, 2005, v. 145 n. 6, p. 775-784 | en_US |
dc.identifier.issn | 0007-1188 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171333 | - |
dc.description.abstract | In coronary arteries, bradykinin opens endothelial intermediate- and small-conductance Ca 2+-sensitive K + channels (IK Ca and SK Ca) and, additionally, releases epoxyeicosatrienoic acids (EETs) from the endothelium. To clarify the involvement of these pathways in endothelium-dependent myocyte hyperpolarization, bradykinin-induced electrical changes in endothelial cells and myocytes of porcine coronary arteries (following nitric oxide (NO) synthase and cyclooxygenase inhibition) were measured using sharp microelectrodes. Hyperpolarization of endothelial cells by bradykinin (27.0±0.9 mV, n = 4) was partially inhibited (74%) by blockade of IK Ca and SK Ca channels using 10 μM TRAM-39 (2-(2-chlorophenyl)-2,2- diphenylacetonitrile) plus 100 nM apamin (leaving an iberiotoxin-sensitive component), whereas the response to substance P was abolished. After gap junction blockade with HEPES, (N-(2-hydroxyethyl)piperazine-N′-(2- ethanesulphonic acid)) hyperpolarization of the endothelium by 100 nM bradykinin was abolished by TRAM-39 plus apamin, whereas myocyte hyperpolarization still occurred (12.9 ± 1.0 mV, n = 4). The residual hyperpolarizations to 100 nM bradykinin were antagonized by the EET antagonist, 14,15-EEZE (14,15-epoxyeicosa-5(Z)-enoic acid) (10 μM), and abolished by iberiotoxin. Bradykinin-induced myocyte hyperpolarizations were also reduced by 14,15-EEZE-mSI (14,15-EEZE-methylsulfonylimide) (5,6- and 14,15-EET antagonist), whereas those to exogenous 11,12-EET were unaffected. These data show that bradykinin-induced hyperpolarization of endothelial cells (due to the opening of IK Ca and SK Ca channels) is electrotonically transferred to the myocytes via gap junctions. Bradykinin (but not substance P) also hyperpolarizes myocytes by a mechanism (independent of endothelial cell hyperpolarization) which involves endothelial cell production of EETs (most likely 14,15- and/or 11,12-EET). These open endothelial IK Ca and SK Ca channels and also activate large-conductance calcium-sensitive K + channels (BK Ca) on the surrounding myocytes. © 2005 Nature Publishing Group. All rights reserved. | en_US |
dc.language | eng | en_US |
dc.publisher | John Wiley & Sons Ltd. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0007-1188&site=1 | en_US |
dc.relation.ispartof | British Journal of Pharmacology | en_US |
dc.subject | 11,12-EET | - |
dc.subject | 14,15-EET | - |
dc.subject | 14,15-EEZE | - |
dc.subject | 14,15-EEZE-mSI | - |
dc.subject | 5,6-EET | - |
dc.subject | Bradykinin | - |
dc.subject | EDHF | - |
dc.subject | Endothelium-dependent hyperpolarization | - |
dc.subject | Porcine coronary artery | - |
dc.subject | Substance P | - |
dc.subject.mesh | 8,11,14-Eicosatrienoic Acid - Analogs & Derivatives - Pharmacology | en_US |
dc.subject.mesh | Acetonitriles - Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Apamin - Pharmacology | en_US |
dc.subject.mesh | Bradykinin - Pharmacology | en_US |
dc.subject.mesh | Coronary Vessels - Drug Effects - Physiology | en_US |
dc.subject.mesh | Endothelium, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Muscle Cells - Drug Effects - Physiology | en_US |
dc.subject.mesh | Peptides - Pharmacology | en_US |
dc.subject.mesh | Potassium Channel Blockers - Pharmacology | en_US |
dc.subject.mesh | Potassium Channels, Calcium-Activated - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Receptors, Eicosanoid - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Substance P - Pharmacology | en_US |
dc.subject.mesh | Swine | en_US |
dc.subject.mesh | Trityl Compounds - Pharmacology | en_US |
dc.title | Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: Involvement of potassium channel activation and epoxyeicosatrienoic acids | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1038/sj.bjp.0706256 | en_US |
dc.identifier.pmid | 15895105 | - |
dc.identifier.scopus | eid_2-s2.0-23044461193 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-23044461193&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 145 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.spage | 775 | en_US |
dc.identifier.epage | 784 | en_US |
dc.identifier.isi | WOS:000230588500010 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Weston, AH=7102913361 | en_US |
dc.identifier.scopusauthorid | Félétou, M=7006461826 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.scopusauthorid | Falck, JR=7101749267 | en_US |
dc.identifier.scopusauthorid | Campbell, WB=7402860555 | en_US |
dc.identifier.scopusauthorid | Edwards, G=7402317535 | en_US |
dc.identifier.issnl | 0007-1188 | - |